139 related articles for article (PubMed ID: 7125179)
1. [Substitution of antithrombin III in shock patients].
Blauhut B; Necek S; Vinazzer H; Bergmann H
Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
[TBL] [Abstract][Full Text] [Related]
2. [Antithrombin III substitution in patients in shock].
Vinazzer H; Blauhut B; Bergmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
[TBL] [Abstract][Full Text] [Related]
3. [Substitution of antithrombin III in shock and consumption coagulopathy].
Blauhut B; Bergmann H; Vinazzer H
Wien Klin Wochenschr; 1984 Dec; 96(24):879-81. PubMed ID: 6528617
[TBL] [Abstract][Full Text] [Related]
4. Substitution therapy with an antithrombin III concentrate in shock and DIC.
Blauhut B; Necek S; Vinazzer H; Bergmann H
Thromb Res; 1982 Aug; 27(3):271-8. PubMed ID: 7135359
[TBL] [Abstract][Full Text] [Related]
5. [Use of antithrombin III concentrates].
Vinazzer H
Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.
van Beek EJ; von der Möhlen MA; ten Cate JW; Brandjes DP; Büller HR
Neth J Med; 1994 Nov; 45(5):206-10. PubMed ID: 7830846
[TBL] [Abstract][Full Text] [Related]
7. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
8. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
10. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
13. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
[TBL] [Abstract][Full Text] [Related]
14. Substitution of antithrombin III in shock and DIC: a randomized study.
Blauhut B; Kramar H; Vinazzer H; Bergmann H
Thromb Res; 1985 Jul; 39(1):81-9. PubMed ID: 4035650
[TBL] [Abstract][Full Text] [Related]
15. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
[TBL] [Abstract][Full Text] [Related]
16. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
17. Substitution of antithrombin III.
Breddin HK; Kirchmaier CM
Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
[TBL] [Abstract][Full Text] [Related]
18. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
Nakagawa M
Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombin III substitution in dialysis-dependent renal insufficiency].
Schrader J; Köstering H; Kramer P; Scheler F
Dtsch Med Wochenschr; 1982 Dec; 107(48):1847-50. PubMed ID: 7140568
[TBL] [Abstract][Full Text] [Related]
20. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
